GASTRIC NEOPLASMS

Clinical trials for GASTRIC NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new GASTRIC NEOPLASMS trials appear

Sign up with your email to follow new studies for GASTRIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Major cancer trial tests new weapon against aggressive stomach tumors

Disease control Completed

This large, completed Phase 3 trial tested whether adding the immunotherapy drug pembrolizumab to the standard first-line treatment (trastuzumab plus chemotherapy) could better control advanced HER2-positive stomach or gastroesophageal junction cancer. It involved 738 participant…

Matched conditions: GASTRIC NEOPLASMS

Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

GASTRIC NEOPLASMS

Get alerted when new GASTRIC NEOPLASMS trials appear

Major cancer trial tests new weapon against aggressive stomach tumors